What We're Reading: Page
Industry reads hand-picked by our editors
Jan 18, 2024
-
The 19th News
Moms are still struggling to get RSV shots for their babies
-
The Wall Street Journal
Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs
-
San Francisco Business Times
Bay Area biotech Sangamo puts entire Peninsula headquarters up for sublease
-
ApexOnco
Car-T comes full circle
Jan 17, 2024
-
Politico
Why health care experts are so concerned about fishing boats
-
The Wall Street Journal
Many Cancers Are on the Rise in the U.S., Even as Overall Deaths Fall
-
BioSpace
GSK Raises $1.24B by Selling Stake in Consumer Health Spin-Off Haleon
-
KFF Health News
Trump Official Who OK’d Drugs From Canada Chairs Company Behind Florida’s Import Plan
Jan 16, 2024
-
The Wall Street Journal
Medicare Patients on Pricey Drugs Are Saving Big This Year
-
CNBC
Cancer drugs: Renewed interest in ADCs will continue in 2024
-
Reuters
Trade union opposes possible split-up of Germany’s Bayer
-
AP News
Vivek Ramaswamy suspends his 2024 Republican presidential bid and endorses rival Donald Trump
Jan 12, 2024
-
The Wall Street Journal
Cancer Is Striking More Young People, and Doctors Are Alarmed and Baffled
-
MIT Technology Review
The innovation that gets an Alzheimer’s drug through the blood-brain barrier
-
LifeSciVC
Biotech Venture Ecosystem: Quick Health Check
Jan 11, 2024
Jan 10, 2024
Jan 09, 2024
-
Bloomberg
Bayer Pharma Head Sees Brighter Future With Deals, New Drugs
-
Nature Medicine
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
-
The New York Times
F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.
-
Endpoints News
Exelixis cuts 175 staffers to prioritize late-stage drug development
Previous
